Kevin David Costa
Corporate Officer/Principal en Icahn School of Medicine at Mount Sinai .
Cargos activos de Kevin David Costa
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 01/01/2009 | - |
Historial de carrera de Kevin David Costa
Antiguos cargos conocidos de Kevin David Costa.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
| NOVOHEART HOLDINGS INC. | Director Técnico/Científico/I+D | 01/01/2017 | - |
| Fundador | 28/04/1964 | - |
Formación de Kevin David Costa.
| Boston University | Graduate Degree |
| University of California San Diego | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Canadá | 2 |
| Israel | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Novoheart Holdings, Inc.
 Novoheart Holdings, Inc. BiotechnologyHealth Technology Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Kevin David Costa
- Experiencia
